Related Experiment Videos
ABO histo-blood group system-incompatible allografting
Urs Nydegger1, Paul Mohacsi, Simon Koestner
1Swiss Cardiovascular Center, University Clinic for Cardiovascular Surgery and University for Cardiology, Inselspital, CH-3010 Bern, Switzerland. info@immune-complex.ch
International Immunopharmacology
|December 14, 2004
Summary
Histo-blood group systems, including ABO, are crucial in organ transplantation. Strategies to manage ABO antibodies improve graft survival and reduce rejection in ABO-mismatched transplants.
Area of Science:
- Immunology
- Transplantation Science
- Genetics
Background:
- Histo-blood group systems, beyond erythroid cells, are increasingly recognized for their role in transplantation.
- The ABO blood group system is particularly significant, with ABO-mismatch strategies used in kidney and heart transplants.
Purpose of the Study:
- To review current knowledge on the ABO histo-blood group system's role in solid organ transplantation.
- To discuss recent advancements in managing ABO antibodies to prevent hyperacute rejection.
Main Methods:
- Overview of recent scientific literature on ABO blood group system and transplantation.
- Discussion of therapeutic strategies for ABO-mismatched grafts, including plasma exchange and immunosuppression.
Main Results:
- ABO antibodies can cause hyperacute rejection in ABO-mismatched transplants.
- Therapeutic interventions like plasma exchange and targeted immunosuppression (e.g., rituximab) can mitigate anti-A/B antibody effects.
- Successful management of ABO-mismatched grafts is becoming more feasible.
Conclusions:
- The ABO blood group system plays a critical role in solid organ transplantation outcomes.
- Effective management of ABO antibodies is essential for successful ABO-mismatched transplantation.
- Further research into histo-blood group systems will likely enhance graft-host interactions and transfusion therapies.